Distinguished Scientist (executive Director), Asset Development Team Leader

Merck Merck · Pharma · NJ

Distinguished Scientist (Executive Director) at Merck, leading clinical research for oncology indications and vaccines. Responsibilities include planning, directing, and overseeing the entire clinical development cycle, from study design to regulatory reporting and publication. The role involves managing cross-functional teams, interacting with key opinion leaders, and maintaining scientific knowledge in the field.

What you'd actually do

  1. The Executive Director has primary responsibility for the planning and directing clinical research activities involving new or marketed drugs for oncology indications.
  2. The Executive Director will manage and oversee the entire cycle of clinical development, including study design, initiation, execution, monitoring, analysis, regulatory reporting, publication, and presentation at national and international meeting.
  3. They will provide internal scientific leadership for cross-functional areas supporting clinical trials and will interact externally with key opinion leaders.
  4. Evaluating pre-clinical and translational work for the purpose of generating early clinical development plan and Investigational New Drug applications
  5. Developing clinical development strategies for investigational or marketed vaccines that incorporate the latest scientific developments, regulatory requirements, the competitive landscape, and commercial considerations.

Skills

Required

  • Clinical Development
  • Clinical Research Methods
  • Detail-Oriented
  • Drug Safety Surveillance
  • Ethical Standards
  • Exercises Judgment
  • Innovation
  • Leadership
  • Professional Integrity
  • Protocol Development
  • Scientific Leadership
  • Scientific Writing

What the JD emphasized

  • Clinical research training and experience required
  • Minimum of 5 years of industry experience in drug development or biomedical research experience in academia or an equivalent combination of academic and industry experience.
  • Minimum of 3 years of clinical and/or safety medicine experience
  • Demonstrated record of scientific scholarship and achievement
  • Understanding of full E2E drug development process and ideally candidate would have in-depth experience in early and/or late development.
  • Has demonstrated success in being a critical team member for multiple studies and protocols
  • Knowledge and ability to originate new program ideas and recommends expansion or curtailment of clinical trials on the basis of results and/or scientific information, including business development and in-licensing opportunities.
  • Good evidence of an ability to devise and implement strategic initiatives across functional groups and global pharma teams
  • Demonstrated experience in the design, implementation, and analysis of clinical trials, including safety
  • Strong interpersonal skills, as well as the ability to function in a team environment are essential
  • High level of verbal and written communication, including presentation skills.
  • Strong learning agility and growth mindset